Publications by authors named "Susan Cleator"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

45

Total Likes

71

Extended Reach

79,505

Social Features

28
T
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.
Ian H Kunkler, Nicola S Russell, Niall Anderson, Richard Sainsbury, J Michael Dixon, Susan Cleator

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menopausal hormone therapy for breast cancer patients: what is the current evidence?
Sarah Glynne, James Simon, Anthony Branson, Stephen Payne, Louise Newson, Susan Cleator

Menopause· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study.
A Murray Brunt, Fay H Cafferty, Duncan Wheatley, Mark A Sydenham, Anna M Kirby, Susan Cleator

Radiother Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: a systematic review and meta-analysis.
Ahmed Ezzat, Dhurka Shanthakumar, Naomi Laskar, Ramsey I Cutress, Dimitri Hadjiminas, Susan Cleator

BMJ Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden.
James Alexander Korolewicz, Bernhard Scheiner, Claudia A M Fulgenzi, Antonio D'Alessio, Alessio Cortellini, Susan Cleator

Chemotherapy· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in Fusion-Positive, Estrogen Receptor-Positive Breast Cancer After Progression on a Cyclin-Dependent Kinase 4/6 Inhibitor.
Elisa Fontana, Gonzalo Torga, Raluca Fostea, Susan Cleator, Ernesto Wasserman

JCO Precis Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study.
Paul T R Thiruchelvam, Daniel R Leff, Amy R Godden, Susan Cleator, Simon H Wood

Lancet Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Ben P Haynes, Gene Schuster, Richard Buus, Anastasia Alataki, Ophira Ginsburg, Susan J Cleator

Breast Cancer Res Treat· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.
Georgios Nteliopoulos, Karen Page, Allison Hills, Karen Howarth, Warren Emmett, Susan Cleator

Breast Cancer Res Treat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial.
Samantha Nimalasena, Lone Gothard, Selvakumar Anbalagan, Steven Allen, Victoria Sinnett, Susan Cleator

Int J Radiat Oncol Biol Phys· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, Susan Cleator

Lancet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.
Raoul Charles Coombes, Karen Page, Raheleh Salari, Robert K Hastings, Anne Armstrong, Susan Cleator

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac safety evaluation in cancer clinical trials.
Dorothy M Gujral, Susan J Cleator, Sanjeev Bhattacharyya

Eur J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety of Early Adjuvant Internal Mammary Lymph Node Irradiation following Mastectomy and Immediate Autologous Reconstruction.
Hazim Sadideen, Susan Cleator, Patti McNaught, Simon Wood, Navid Jallali

Plast Reconstr Surg· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk.
Lynsey Rice, Christy Goldsmith, Melanie Ml Green, Susan Cleator, Patricia M Price

Breast Cancer (Dove Med Press)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic inflammatory response syndrome in a patient diagnosed with high grade inflammatory triple negative breast cancer: a case report of a potentially rare paraneoplastic syndrome.
Piers R Boshier, Rosie Sayers, Dimitri J Hadjiminas, Charles Mackworth-Young, Susan Cleator

Exp Hematol Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient attitudes towards undergoing additional breast biopsy for research.
Farhan Naim, Rachel Ballinger, Ines Rombach, Dimitri J Hadjiminas, Ragheed Al-Mufti, Susan J Cleator

Breast· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the presence of small volume disease in the sentinel node an indication for axillary clearance?
Darren K Patten, Daniel R Leff, Zubair Wani, Susan J Cleator, Carlo Palmieri

Breast· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Nancy U Lin, Eric P Winer, Duncan Wheatley, Lisa A Carey, Stephen Houston, Susan Cleator

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should Internal Mammary Lymph Node Biopsy be A Routine Step in Recurrent Breast Cancer? Report of Three Cases With Negative Axilla and Positive Internal Mammary Node.
Stavros E Chatzopoulos, Kasim A Behranwala, Parveen Jayia, Ragheed Al-Mufti R, Susan J Cleator

World J Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key.
Nicole Tsim, Andrew J Healey, Adam E Frampton, Nagy A Habib, Devinder S Bansi, Susan J Cleator

Ann Surg Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome.
Jonathan Krell, Colin R James, Deep Shah, Ondrej Gojis, Adrian Lim, Susan Cleator

Clin Breast Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era.
Carlo Palmieri, Deep Shah, Jonathan Krell, Ondrej Gojis, Katy Hogben, Susan Cleator

Clin Breast Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rechallenging with anthracyclines and taxanes in metastatic breast cancer.
Carlo Palmieri, Jonathan Krell, Colin R James, Catherine Harper-Wynne, Vivek Misra, Susan Cleator

Nat Rev Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis